Provider

Medeacom s.r.l.info@medeacom.orgwww.medeacom.org

Scientific Committee:Tom Treasure - LondonGiuseppe di Maria - CataniaMarcello Migliore - Catania

Honorary PresidentGiulio Deodato - Catania

Speakers and moderatorInternational Semih Halezeroglu - Istambul, TurkeyLex Maat Rotterdam, HollandTom Treasure - London, UKRobert Rintoul - Cambridge, UKRiad Younes - Sao Paolo, Brasil

NationalMario Barone - MessinaMassimo Cajozzo - PalermoCaterina Casadio - TorinoPietro Comba - RomaPierluigi Filosso - TorinoFrancesco Monaco - MessinaMaurizio Monaco - MessinaClaudio Mineo - RomaUliano Morandi - ModenaAlfredo Mussi - PisaMaurizio Nicolosi - CataniaEnrico Potenza - CataniaVenerando Rapisarda - CataniaSalvino Saita - CataniaEctor Soto Parra - CataniaPaolo Vigneri - Catania

Per partecipare al corso è necessaria l’iscrizione online sul sito www.medeacom.org

crediti ecm 11

sponsored by

Segreteria Organizzativa

Salvo Tomasellocongressidgs@hotmail.it

tel. 393 9784859

Aula Magna Policlinico University Hospital

Update and new directions on sUrgery for mesothelioma

II Mediterranean Symposium in Thoracic Oncology

16 April 2015 - catania, italyUniversity of CataniaDepartment of SurgerySection of Thoracic Surgery

SeSSion 3 Randomised controlled studies Moderators Semih Halezeroğlu, Alfredo Mussi, Caterina Casadio

11:30-11:50 Pleuro pneumonectomy and EPP so much for that? Tom Treasure11:50-12:10 Pleurectomy or talc pleurodesis: the MesoVATS trial explored Robert Rintoul12:10-12:30 The Erasmus trial: learning lessons Alexander Maat12:30-12:50 MARS-2 how will that work out? Tom Treasure

12:50-13:00 Discussion

SeSSion 4 Lunch session and poster session Moderators Tom Treasure, Maurizio Nicolosi, Enrico Potenza13:00-14:30 What medical students think about mesothelioma? Medical students of the Faculty of Medicine

SeSSion 5 Modern treatment: science and the real world Moderators Uliano Morandi, Maurizio Monaco, Tom Treasure

15:00-15:15 EORTC - CALGB models validation in a cohort of surgical patients Pier Luigi Filosso15:15-15:30 Pleurectomy and hyperthermic intra-operative chemotherapy Marcello Migliore15:30-15:45 Management of recurrence after initial surgery SemihHalezeroğlu15:45-16:00 Chemoradiotherapy and novel treatment option: the old and the new Hector Soto Parra

16:00-16:30 Discussion

SeSSion 6 Future direction Moderators Alexander Maat, Tommaso Claudio Mineo, Marcello Migliore

16:30-16:50 Willsurgeryevercontrolmesothelioma?Attempttofindananswer Tom Treasure16:50-17:10 Is the patient with mesothelioma without hope? Alexander Maat17:10-17:30 Are guidelines for Mesothelioma useful? Riad Younes17:30-17:50 New treatment algorithm and future direction Tom Treasure17:50-18:00 Discussion

18:00-18:15 Take home messages Marcello Migliore, Tom Treasure

18:15-18:45 Evaluation CME tests and closing remarks

08:30-09:30 Registration09:30-09:50 Introduction and Greetings

SeSSion 1 epidemiologyModerators Mario Barone, Massimo Cajozzo, Giuseppe Di Maria09:50-10:05 Epidemiology of mesothelioma in Europe Giuseppe Di Maria10:05-10:20 The case of Biancavilla in Sicily Pietro Comba 10:20-10:35 High Risk of pleural plaques in construction workers operating in Biancavilla: case-control study Venerando Rapisarda 10:35-10:45 Discussion

SeSSion 2 What’s new in diagnosis of mesothelioma Moderators Alexander Maat, Marcello Migliore, Salvatore Saita10:45-11:00 Biomarkers and Prognostic factors Paolo Vigneri11:00-11:15 Pleural plaques and mesothelioma: what is the role of VATS Francesco Monaco11:15-11:30 Discussion

Dear Colleagues and Friends,Following the success of the last Symposium in 2014, this year’s Symposium will continue to investigate on what is new in thoracic oncology, and the chosen neoplasm is the mesothelioma. Between the primary pleural neoplasm, meso-thelioma is the most frequent, and heralds a dismal survival. Literature is full of papers reporting treatment for malignant pleural mesothelioma, and most patients are treated with “curative” intent using pleurectomy, pleuropneumec-tomy or with simple talc pleurodesis as a palliative surgery. Although there are very many clinical reports of surgical removal of mesothelioma, there is a great confusiononhoweffectiveitsremovalinobtainingcure,andwhatarethelimitsbeyondwhichsurgeryoffersnofurtherbenefittotheseunfortunatepatients.The open questions are numerous, and we hope to answer to some of them. As in the last year Professor Tom Treasure of the University College of London joined usasaScientificAdvisor.Oneofthemainaimsofthesymposiumistolinksciencewith clinical practice in an informal and interactive atmosphere. The symposium is intended to bridge across special interests: oncology, surgery, respiratory medi-cine, pathology and health care analysts. It is for everyone: surgeons, physicians, trainees, nurses and medical students. A poster session in thoracic oncology has been again organised to give an opportunity for surgeons in training and medical students to present their studies. As you can see there is a ‘total immersion’ aca-demic program, followed by networking and drinks reception and evening. You can also take the advantage to visit Sicily, one of the pearls of Mediterranean Sea. Sicily is a fascinating isle full of history, beauty and vitality.

Welcome To Sicily